Asiatic Laboratories (DHA:ASIATICLAB) Total Stockholders Equity: BDT0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:ASIATICLAB Asiatic Laboratories Ltd DHA:ASIATICLAB
32 GF Score
Price BDT142.80
! 1 Warning Sign
View Full Analysis

What is Asiatic Laboratories Total Stockholders Equity?

Asiatic Laboratories DHA:ASIATICLAB +0.42% 32 Total Stockholders Equity is BDT0.00 Mil as of . 20. GuruFocus rates DHA:ASIATICLAB with a GF Score™ of 32/100. The stock has 1 warning sign investors should review.

Asiatic Laboratories's Total Stockholders Equity for the quarter that ended in . 20 was BDT0.00 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Asiatic Laboratories's Book Value per Share for the quarter that ended in . 20 was BDTN/A. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Asiatic Laboratories's Debt-to-Equity for the quarter that ended in . 20 was .

Asiatic Laboratories  (DHA:ASIATICLAB) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Asiatic Laboratories's Book Value per Share for the quarter that ended in . 20 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-)/0
=N/A

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Asiatic Laboratories's Debt-to-Equity for the quarter that ended in . 20 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=( + ) /
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asiatic Laboratories Total Stockholders Equity Related Terms

Asiatic Laboratories Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Asiatic Laboratories's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asiatic Laboratories Total Stockholders Equity Chart

Asiatic Laboratories Annual Data
Trend
Total Stockholders Equity

Asiatic Laboratories Semi-Annual Data
Total Stockholders Equity
DHA:ASIATICLAB
32GF Score
Asiatic Laboratories Ltd DHA:ASIATICLAB
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of BDT0.00 Mil mean?
Asiatic Laboratories (DHA:ASIATICLAB) has a Total Stockholders Equity of BDT0.00 Mil as of . 20. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Asiatic Laboratories and its competitors.
Is Asiatic Laboratories' Total Stockholders Equity too high?
Asiatic Laboratories' current Total Stockholders Equity is BDT0.00 Mil. Overall, Asiatic Laboratories has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Asiatic Laboratories' Total Stockholders Equity compare to ZTS and UTHR?
Asiatic Laboratories' Total Stockholders Equity of BDT0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Drug Manufacturers company?
A good Total Stockholders Equity depends on the Drug Manufacturers industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Asiatic Laboratories and its competitors. Asiatic Laboratories's current Total Stockholders Equity is BDT0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asiatic Laboratories stock overvalued right now?
Asiatic Laboratories (DHA:ASIATICLAB) has a current Total Stockholders Equity of BDT0.00 Mil. The current Total Stockholders Equity is BDT0.00 Mil. Asiatic Laboratories' overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Asiatic Laboratories (DHA:ASIATICLAB), the current Total Stockholders Equity is BDT0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Asiatic Laboratories Business Description

Address Siddeshwari Circular Road, 42-43, Treasure Island (5 th Floor) Shantinagar, Dhaka, BGD, 1217
Asiatic Laboratories Ltd is engaged in manufacturing and marketing of a wide range of the rapeutical medicines pharmaceutical products in the categories of Biological, Non-Biological & Sterile Pharmaceutical dosage. It has 80 generic molecules comprising therapeutic classes like antibiotics, antihistamines, bronchodilators, vitamins-minerals, antiulcerants, laxatives, gastroprokinetics, antihematinic, anthelmentics, CNS drugs, respiratory drugs, NSAIDs, dermatological preparations and sterile ophthalmic preparations.
32GF Score

Get the complete analysis for DHA:ASIATICLAB

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT142.80
Price